We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.51 | 3.02 | 4.00 | - | 51,323 | 08:00:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 7.78M | 1.33M | 0.0045 | 7.80 | 10.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/11/2023 11:45 | It would be nice to see management buy some shares after today's disappointing announcement. They are great at clipping the ticket month in and month out but if they really believe in the Company and its technology/products/ | here we go again | |
30/11/2023 11:04 | Wish I had got out at our lofty 10p the other year, maybe another year before we see that again unless they start selling meaningful amounts of the products/services. Pike and co need to start working for a living | the bull | |
30/11/2023 09:41 | This is a wonderful buying opportunity before Proteome Science start to announce all the positive news over the coming weeks/months. US lab opening, 6-plex isotopic reagents, Alzheimers interest(?), 32-plex isobaric reagents, Stroke test release, plus "other stuff"! STRONG BUY | wasjobber | |
30/11/2023 09:22 | Why will it get worse? | 049balt | |
30/11/2023 08:27 | The goatcurse strikes (yet) again. | monte1 | |
30/11/2023 07:43 | Well my 6p y/e has just been scuppered! W41 | wrighty41 | |
30/11/2023 07:30 | Return to loss is a shame Not sure why PRM expexts macro economic improvement. I see it only continuing to worsen.... potentially getting much, much worse | stocktastic | |
30/11/2023 07:22 | What an absolute shower. | peverill | |
24/11/2023 14:56 | Oh come on peverill! shareholders, stfu. | dominiccummings | |
24/11/2023 12:00 | Anything in this for shareholders,old or new.Or just a Directors gravy train. | peverill | |
24/11/2023 11:31 | I've never heard the word "Publicity" and "Proteome Sciences" in the same sentence. I'm not sure they know what it means, they don't have proper Public Relations. Yet. | wasjobber | |
24/11/2023 10:58 | wasjobber, Yes I agree, I assume Proteome Sciences are getting ready for the imminent opening and publicity of their new USA laboratory in San Diego | pools2 | |
24/11/2023 10:35 | much the same as the turnstiles at Rushden & Diamonds AFC it seems, more patents required!!! | elpirata | |
24/11/2023 09:35 | Interesting that Proteome Sciences have just updated (at last) and packed their website with information. As if they think a lot more people (Americans) are going to be looking at it. :) STRONG BUY | wasjobber | |
24/11/2023 08:35 | How is the Toll Booth scenario playing out here.??? | peverill | |
20/11/2023 18:49 | Where fgnoms, lamby, Saul and the rest of the old gang these days? | sandcrab2 | |
17/11/2023 19:31 | 'the chuckle brother' BOL! | elpirata | |
17/11/2023 15:05 | Jeremy Haigh had the measure of Chris Pearce and the chuckle brother quite early on I gather | canaletto | |
16/11/2023 17:41 | Always enough to pay the exorbitant wages though,for what they actually do. | peverill | |
15/11/2023 11:51 | The grift that keeps on grifting, all year long. | james japp | |
15/11/2023 11:49 | They are not in it for the money. nor are prm investors evidently, they should change the co. name to philanthropic sciences plc | elpirata | |
15/11/2023 11:43 | They are not in it for the money. Directors emoluments notwithstanding natch. | monte1 | |
15/11/2023 11:35 | Oh come on pev, what about those 'meaty' new patents & what on earth did you expect prm to come up with, lucrative commercial contracts with £££ attached??? | elpirata |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions